The Dual Vitamin D Pathways: Considerations for Adequate Supplementation

The Dual Vitamin D Pathways: Considerations for Adequate Supplementation


Identification: nnj_jf10A1
Issue: January-February 2010
Volume: Vol. 37, No. 1
Credits (Post Test and/or Evaluation Required)
Available until 02/29/2012
  • 1.40 - CH
  • 80.00 - Rx

Standard: $30.00

Description

This article is available to members for free.

Goal: To provide an overview of the treatment of vitamin D deficiency and insufficiency in patients with CKD with vitamin D supplementation via the endocrine and autocrine pathways.

Objectives:

  1. Discuss the physiologic and molecular functions of vitamin D.
  2. Describe the pathogenesis of secondary hyperparathyroidism.
  3. Discuss non-kidney related outcomes that result from lack of adequate therapy.
  4. Understand the rationale for dual therapies in Stage 5 chronic kidney disease.


Statement of Disclosure: The author has disclosed that she is an employee of Cytochroma, Inc., a clinical stage specialty pharmaceutical company developing vitamin D products for commercialization.

Acknowledgment: The author would like to acknowledge Robert P. Heaney, MD, for his article "Vitamin D in Health and Disease," which served as a primary resource in the development of this article.

Author(s)

Credits Available


Expired On: Feb 29, 2012

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content